Evaluation of the selectivity of potential in vitro inhibitors of human CYP2E1

被引：0
|
作者：
Matthews, Anne
Paul, Daniel S.
Hall, Michael
机构：
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
51
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 Allele Frequencies in Iranian Populations
    Shahriary, Ghazaleh Mohammadzadeh
    Galehdari, Hamid
    Jalali, Amir
    Zanganeh, Fatemeh
    Alavi, Seyed Mohammad Reza
    Aghanoori, Mohammad Reza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6505 - 6510
  • [2] A systematic evaluation of microRNAs in regulating human hepatic CYP2E1
    Wang, Yong
    Yu, Dianke
    Tolleson, William H.
    Yu, Li-Rong
    Green, Bridgett
    Zeng, Linjuan
    Chen, Yinting
    Chen, Si
    Ren, Zhen
    Guo, Lei
    Tong, Weida
    Guan, Huaijin
    Ning, Baitang
    BIOCHEMICAL PHARMACOLOGY, 2017, 138 : 174 - 184
  • [3] Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro
    Hou, De-Fu
    Wang, Shui-Liang
    He, Zhi-Min
    Yang, Fang
    Chen, Zhu-Chu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2007, 298 (1-2) : 93 - 100
  • [4] Expression of CYP2E1 in human nasopharynx and its metabolic effect in vitro
    De-Fu Hou
    Shui-Liang Wang
    Zhi-Min He
    Fang Yang
    Zhu-Chu Chen
    Molecular and Cellular Biochemistry, 2007, 298 : 93 - 100
  • [5] TWO COMMON CYP2E1 VARIANTS AND GREATER HUMAN IN VIVO CYP2E1 METABOLIC ABILITY
    Divakaran, Karthika
    Shadley, Jeff D.
    McCarver, D. Gail
    DRUG METABOLISM REVIEWS, 2007, 39 : 368 - 369
  • [6] CHLORZOXAZONE IS METABOLIZED BY HUMAN CYP1A2 AS WELL AS BY HUMAN CYP2E1
    ONO, S
    HATANAKA, T
    HOTTA, H
    TSUTSUI, M
    SATOH, T
    GONZALEZ, FJ
    PHARMACOGENETICS, 1995, 5 (03): : 143 - 150
  • [7] Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism
    Lee, Anna M.
    Joshi, Meenal
    Yue, Jiang
    Tyndale, Rachel F.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 552 (1-3) : 151 - 158
  • [8] Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform
    Lewis, DFV
    Bird, MG
    Dickins, M
    Lake, BG
    Eddershaw, PJ
    Tarbit, MH
    Goldfarb, PS
    XENOBIOTICA, 2000, 30 (01) : 1 - 25
  • [9] Assessing specificity of indazole derivatives as inhibitors to CYP2E1
    Hart, Hannah
    Miller, Grover
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [10] Structure-activity relationship (SAR) study of human CYP2E1 inhibitors
    Raunio, H.
    Neshybova, S.
    Juvonen, R.
    TOXICOLOGY LETTERS, 2005, 158 : S50 - S50
12345